Theranexus (EPA:ALTHX) | Finanzwire

Basculer en Français

9979	Companies
202294	Keywords
132916	Articles
107422	Press releases

Home
Companies
Theranexus

BRIEF

published on 02/25/2026 at 18:05, 7 days 19 hours ago

THX Pharma increases the resources of its liquidity contract

Liquidity Contract Euronext Growth Biopharmaceutical Financial Resources THX Pharma
BRIEF

published on 02/19/2026 at 18:05, 13 days 19 hours ago

THX Pharma strengthens its financial position as of December 31, 2025

Treasury Partnership Batten-1 TX01 Biocodex
BRIEF

published on 02/19/2026 at 18:05, 13 days 19 hours ago

THX Pharma Announces Strong Cash Position at Year-End

Cash Position THX Pharma Biocodex Agreement Batten-1 Program TX01 Development
PRESS RELEASE

published on 02/19/2026 at 18:00, 13 days 19 hours ago

THX Pharma Reports Its Cash Position as of December 31, 2025
THX Pharma (Theranexus) announces cash position of €7.8 million as of Dec 31, 2025. Pro forma cash position reaches €21.7 million with incoming payment from Biocodex agreement. Company focused on rare neurological diseases treatments development

Cash Position Rare Neurological Diseases Therapeutic Solutions THX Pharma Biocodex Agreement
BRIEF

published on 02/12/2026 at 18:05, 20 days 19 hours ago

THX Pharma and Biocodex conclude a major strategic agreement

Webinar Strategic Agreement THX Pharma Neurological Medications Biocodex
BRIEF

published on 02/12/2026 at 18:05, 20 days 19 hours ago

THX Pharma Announces Webinar on Strategic Agreement with Biocodex

Webinar Batten-1 Strategic Agreement THX Pharma Biocodex
PRESS RELEASE

published on 02/12/2026 at 18:00, 20 days 19 hours ago

THX Pharma to Host a Webinar to Discuss Its Strategic Agreement with Biocodex
THX Pharma to host webinar discussing strategic agreement with Biocodex, including licensing terms and development outlook. Webcast on February 17, 6:00 p.m. CET. More info at theranexus.com

Webinar Strategic Agreement Neurological Diseases THX Pharma Biocodex
BRIEF

published on 02/10/2026 at 18:05, 22 days 19 hours ago

Strategic Licensing Agreement for Rare Disease Treatments

Rare Diseases Strategic Agreement Licensing Deal THX Pharma Biocodex
BRIEF

published on 02/10/2026 at 18:05, 22 days 19 hours ago

Strategic agreement between THX Pharma and Biocodex for three rare diseases

Rare Diseases License Agreement THX Pharma Biocodex Batten-1 And TX01
PRESS RELEASE

published on 02/10/2026 at 18:00, 22 days 19 hours ago

THX Pharma and Biocodex announce a strategic licensing agreement covering three rare diseases
Biocodex acquires licenses from THX Pharma to develop Batten-1 globally and TX01 in US and Canada. Deal worth up to €173M includes milestone payments and double-digit royalties

Batten-1 Licenses TX01 THX Pharma Biocodex

1 2 ... 8

Accesswire

Published on 03/05/2026 at 13:40, 14 minutes ago

Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
Published on 03/05/2026 at 13:30, 24 minutes ago

Vox Royalty Provides 2026 Guidance and Increases Quarterly Dividend
Published on 03/05/2026 at 13:30, 24 minutes ago

Nextech3D.ai Expands AI Event Technology Into New Markets and Implements 20%-30% Enterprise Price Increase
Published on 03/05/2026 at 13:00, 54 minutes ago

Revolve Signs Definitive Agreements for Portfolio of 16 Distributed Generation Solar Projects in Mexico
Published on 03/05/2026 at 13:00, 54 minutes ago

Field Work Identifies New Mineralized Trend and Additional Gold Targets at Golden Rose

View all ACCESSWIRE

EQS Group

Published on 03/05/2026 at 13:43, 11 minutes ago

Healthcare specialist SHS Capital exits AMW, a leading specialty pharma company, and continues partnership by reinvesting with its current fund as part of a syndicate of investors
Published on 03/05/2026 at 13:25, 29 minutes ago

Huawei and SOLUM Unveil Shop-in-Shop Smart Converged Network Solution to Accelerate Retail Intelligence
Published on 03/05/2026 at 13:06, 47 minutes ago

HENSOLDT acquires Nedinsco and expands its European presence
Published on 03/05/2026 at 13:05, 49 minutes ago

Norgine announces £23 million new investment as part of more than £50 million committed to expanding medicines manufacturing in Wales
Published on 03/05/2026 at 13:00, 54 minutes ago

Huawei Launches AI Data Platform to Bridge Models and Business Value

Les Echos

Published on 03/05/2026 at 13:20, 33 minutes ago

Voting rights
Published on 03/05/2026 at 07:30, 6 hours 24 minutes ago

Share buyback finalized
Published on 03/04/2026 at 23:50, 14 hours 4 minutes ago

Total number of voting rights and shares making up the share capital at February 28, 2026
Published on 03/04/2026 at 18:00, 19 hours 54 minutes ago

Disclosure of Share Capital and Voting Rights as of February 28, 2026
Published on 03/04/2026 at 17:45, 20 hours 9 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE